Tirzepatide is a dual incretin receptor agonist, designed to activate both GIP and GLP-1 receptors simultaneously. This dual-pathway mechanism is a focus of ongoing metabolic and endocrine research, allowing investigators to study synergistic signaling effects on glucose regulation, appetite pathways, and systemic energy balance. Supplied as a sterile, lyophilized powder for laboratory research use only.
Tirzepatide
Lyophilized Powder, ≥99% Purity
$70.00 – $155.00Price range: $70.00 through $155.00
Tirzepatide is a dual GIP/GLP-1 receptor agonist research peptide studied for its role in glucose regulation, insulin signaling, and appetite-pathway research.
Additional information
| Size | 5MG, 10MG, 15MG |
|---|
This compound is used in studies of insulin secretion, glucose homeostasis, and beta-cell signaling models. Its extended activity profile supports long-term observation of hormonal timing and metabolic feedback. Reconstitute with bacteriostatic water and store refrigerated at 2°C–8°C; apply precise reconstitution math to maintain consistent molarity across research batches.
Store between 2°C and 8°C. Protect from light. Reconstitute only the amount needed.
Tirzepatide is supplied strictly for laboratory research use only. It is not intended for human or animal consumption, medical treatment, or diagnostic purposes. All handling and use must comply with applicable laboratory regulations and research standards.
For laboratory research use only. Not for human or veterinary consumption.
Related products
SLU-PP-332
Lyophilized Powder, ≥99% Purity
Retatrutide
Lyophilized Powder, ≥99% Purity
Semaglutide
Lyophilized Powder, ≥99% Purity
MOTS-c
Lyophilized Powder, ≥99% Purity

